Michael Edelstein
Overview
Explore the profile of Michael Edelstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
2111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Enter B, de Zeeuw J, Bakar O, Bakhlakh S, Schim van der Loeff M, Boersma C, et al.
Vaccine
. 2025 Feb;
50:126827.
PMID: 39908781
Introduction: In the Netherlands HPV-vaccination uptake is low among females with a Moroccan or Turkish migration background. The aim of this study was to identify health system barriers to HPV-vaccine...
2.
Essa-Hadad J, Jansen D, Vervoort J, Edelstein M
Isr J Health Policy Res
. 2024 Dec;
13(1):71.
PMID: 39639350
Background: Over 1.9 million Arabs live in Israel and constitute 21% of the total population. Despite being a disadvantaged minority population with wide gaps in health indicators, Arabs have higher...
3.
Edelstein M, Shibli H, Bornstein J
Vaccine
. 2024 Nov;
44:126548.
PMID: 39612803
In Israel, The Human Papilloma Virus (HPV) vaccine is recommended to both genders up to age 26. Many 18-26 olds missed their opportunity for vaccination during school. Our study described...
4.
Bernstine T, Spitzer S, Pleban R, Armon-Omer A, Ron A, Kains I, et al.
Sci Rep
. 2024 Nov;
14(1):29291.
PMID: 39592808
The indirect impact of the COVID-19 pandemic on clinical services in peripheral hospitals has not been fully described. We compared the impact of COVID-19 on Cerebral Vascular Accident (CVA) and...
5.
Pazukhina E, Garcia-Gallo E, Reyes L, Kildal A, Jassat W, Dryden M, et al.
BMJ Glob Health
. 2024 Oct;
9(10).
PMID: 39433402
Introduction: A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to...
6.
Ganczak M, Kalinowski P, Twardowski P, Osicka D, Pasek O, Duda-Duma L, et al.
Front Public Health
. 2024 Aug;
12:1380627.
PMID: 39193195
Background: Ukraine has one of the lowest COVID-19 vaccination rates in Europe. This may pose a significant epidemiological risk in the context of the refugee crisis and the fact that,...
7.
Ginn S, Mandwie M, Alexander I, Edelstein M, Abedi M
J Gene Med
. 2024 Aug;
26(8):e3721.
PMID: 39114903
To date, 3,900 gene therapy clinical trials have been completed, are ongoing or have been approved worldwide. Our database brings together global information on gene therapy clinical activity from trial...
8.
Dhiman A, Yom-Tov E, Pellis L, Edelstein M, Pebody R, Hayward A, et al.
NPJ Digit Med
. 2024 Jul;
7(1):194.
PMID: 39033238
We propose a method to estimate the household secondary attack rate (hSAR) of COVID-19 in the United Kingdom based on activity on the social media platform X, formerly known as...
9.
Hussein I, Mohamud H, Hussein A, Luomala O, Kontio M, Edelstein M, et al.
Vaccine
. 2024 Jun;
42(24):126087.
PMID: 38926069
Background: Globally, migrant populations usually experience lower vaccine coverage than the general population. In Finland, the MMR vaccination coverage of Somalis has not been studied specifically, but existing evidence suggests...
10.
Cherri Z, Lau K, Nellums L, Himmels J, Deal A, McGuire E, et al.
J Travel Med
. 2024 Feb;
31(6).
PMID: 38423523
Background: Ensuring vaccination coverage reaches established herd immunity thresholds (HITs) is the cornerstone of any vaccination programme. Diverse migrant populations in European countries have been associated with cases of vaccine-preventable...